ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
03 Sep 2018

Acarix kliniska rådgivare bekräftar validiteten för bolagets omfattande kliniska studieprogram vid ett möte som hölls parallellt med ESC konferensen i München, Tyskland.

PressmeddelandeMalmö den 3 september 2018Acarix kliniska rådgivare bekräftar validiteten för bolagets omfatta...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
30 Aug 2018

Swedish hospitals successfully complete Acarix CADScor®System evaluations vs. current best clinical practice for ruling out Coronary Artery Disease.

Press releaseMalmö, August 30, 2018Swedish hospitals successfully complete Acarix CADScor®System evaluations vs. current best ...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
30 Aug 2018

Svenska sjukhus slutför framgångsrika utvärderingar av Acarix CADScor®System som jämförts med ledande klinisk praxis för att utesluta kranskärlssjukdom.

PressmeddelandeMalmö, 30 augusti 2018Svenska sjukhus slutför framgångsrika utvärderingar av Acarix CADScor®Sys...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
23 Aug 2018

Acarix presenting the CADScor®System at ESC in Munich: A revolutionary technology for early and rapid rule out of Coronary Artery Disease

Press releaseMalmö, Sweden August 23, 2018Acarix presenting the CADScor®System at ESC in Munich:A revolutionary technology for...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
23 Aug 2018

Acarix presenterar CADScor®System vid ESC i München: En revolutionerande teknologi för tidig och snabb uteslutning av kranskärlssjukdom

PressmeddelandeMalmö, 23 augusti, 2018Acarix presenterar CADScor®System vid ESC i München: En revolutionerande teknologi ...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
06 Apr 2018

Acarix CADScor®System, ett avancerat, lättanvänt, initialt test för att utesluta kranskärlssjukdom visas upp och är föremål för expertsymposium på Deutsche Gesellschaft für Kardiologie (DGK 2018)

PressmeddelandeMalmö, Sverige, 6 april 2018Acarix CADScor®System, ett avancerat, lättanvänt, initialt test för ...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
06 Apr 2018

The Acarix CADScor®System – on display and in focus at a key scientific symposium at DGK 2018

Press releaseMalmö, Sweden April 6, 2018Introducing an advanced, easy to use, frontline test to rule out Coronary Artery DiseaseTh...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
09 Jan 2018

DAN-NICADII-studie startas för att bredda tillämpningen av det icke-invasiva Acarix CADScor®System för snabb uteslutning av kranskärlssjukdom

PressmeddelandeMalmö, 9 januari, 2018DAN-NICADII-studie startas för att bredda tillämpningen av det icke-invasiva Acarix...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
09 Jan 2018

DAN-NICADII study to expand the applicability of the non-invasive Acarix CADScor®System for rapid ruling out Coronary Artery Disease

Press releaseMalmö, January 9, 2018DAN-NICADII study to expand the applicability of the non-invasive Acarix CADScor®System for...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
29 Nov 2017

Nya data publicerade i den ledande tidskriften Heart visar att det icke-invasiva Acarix CADScor®System på ett säkert sätt utesluter CAD på några minuter

PressmeddelandeMalmö, 29. november, 2017Nya data publicerade i den ledande tidskriften Heart visar att det icke-invasiva Acarix CA...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
29 Nov 2017

New data published in leading journal Heart proves non-invasive Acarix CADScor®System safely rules out CAD in minutes

Press releaseMalmö, November 29, 2017New data published in leading journal Heart proves non-invasive Acarix CADScor®System saf...
Continue reading
author-avatar acarix
Corporate Information, IR, mfn-lang-de, News, Other Corporate Information
November 18, 2024
12 Oct 2017

Die Diskrepanz zwischen Anstieg stationärer KHK-Diagnostik und Abnahme der Akutereignisse unterstreicht den Bedarf an neuen Testverfahren wie CADScor®System von Acarix

PressemitteilungMalmö, 12. Oktober 2017Die Diskrepanz zwischen Anstieg stationärer KHK-Diagnostik und Abnahme der Akutereigni...
Continue reading
  • «
  • ‹
  • 16
  • 17
  • 18
  • 19
  • 20
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.